Comparison of Adenoma Detection Rate With ENDOCUFF VISION® vs. G-EYE®

Completed · Not applicable

Conditions studied: Adenoma, Colorectal Cancer

In brief

The study is intended to compare the detection rate obtained by performing G-EYE® high definition colonoscopy vs. the detection rate obtained by performing ECV high definition colonoscopy.

Key facts

Study ID

NCT04708951

Run by

Dr. Horst Schmidt Klinik GmbH

People needed

970

Starts

2021-01-01

Expected to finish

2021-10-15

Last updated by the study team

2021-10-22

Who can join

Age: any. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Screening and surveillance population for Adenoma and CRC.
• The patient must understand and sign a written informed consent for the procedure.

You may not qualify if…

• Subjects with inflammatory bowel disease;
• Subjects with a personal history of hereditary polyposis syndrome;
• Subjects with suspected chronic stricture potentially precluding complete colonoscopy;
• Subjects with diverticulitis or toxic megacolon;
• Subjects with prior colonic surgery (exclusion appendectomy)
• Subjects with a history of radiation therapy to abdomen or pelvis;
• Pregnant or lactating female subjects;
• Subjects who are currently enrolled in another clinical investigation.
• Subjects with current oral or parenteral use of anticoagulants, not considered eligible by the investigator.
• Subjects with recent (within the last 3 mounts) coronary ischemia or CVA (stroke)
• Any patient condition deemed too risky for the study by the investigator

Where it is running

• IU Health University Hospital — Indianapolis, Indiana, United States
• NYU Langone Health — New York, New York, United States
• Helios Dr. Horst Schmidt Kliniken Wiesbaden — Wiesbaden, Germany

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.